[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HUP0004015A2 - Három különböző, egyenként legalább egy hatóanyagot tartalmazó rétegből álló monolitikus, orális rendszer - Google Patents

Három különböző, egyenként legalább egy hatóanyagot tartalmazó rétegből álló monolitikus, orális rendszer

Info

Publication number
HUP0004015A2
HUP0004015A2 HU0004015A HUP0004015A HUP0004015A2 HU P0004015 A2 HUP0004015 A2 HU P0004015A2 HU 0004015 A HU0004015 A HU 0004015A HU P0004015 A HUP0004015 A HU P0004015A HU P0004015 A2 HUP0004015 A2 HU P0004015A2
Authority
HU
Hungary
Prior art keywords
delivery system
system containing
oral delivery
per layer
drug per
Prior art date
Application number
HU0004015A
Other languages
English (en)
Inventor
Daniela Acerbi
Ruggero Bettini
Giovanni Caponetti
Pier Luigi Catellani
Paolo Chiesi
Rossela Musa
Paolo Ventura
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of HUP0004015A2 publication Critical patent/HUP0004015A2/hu
Publication of HUP0004015A3 publication Critical patent/HUP0004015A3/hu
Publication of HU225692B1 publication Critical patent/HU225692B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

A találmány szerinti orális, szabályozott hatóanyag-leadású,monolitikus rendszer széteső rétegből, erodálódó rétegből és duzzadórétegből, két külső és egy közbülső rétegből álló három rétegettartalmaz, ahol mindegyik réteg egy vagy több hatóanyagot tartalmaz. Ó
HU0004015A 1997-10-03 1998-10-01 Monolithic system containing one or more drugs, consisting of three layers with different realise mechanizm HU225692B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI002254A IT1295271B1 (it) 1997-10-03 1997-10-03 Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato
PCT/EP1998/006228 WO1999017745A1 (en) 1997-10-03 1998-10-01 Monolithic system containing one or more drugs, consisting of three layers with different release mechanisms

Publications (3)

Publication Number Publication Date
HUP0004015A2 true HUP0004015A2 (hu) 2001-08-28
HUP0004015A3 HUP0004015A3 (en) 2006-06-28
HU225692B1 HU225692B1 (en) 2007-06-28

Family

ID=11377984

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004015A HU225692B1 (en) 1997-10-03 1998-10-01 Monolithic system containing one or more drugs, consisting of three layers with different realise mechanizm

Country Status (14)

Country Link
EP (1) EP1019029B1 (hu)
AR (1) AR043070A1 (hu)
AT (1) ATE248590T1 (hu)
AU (1) AU9629198A (hu)
BR (1) BR9815248A (hu)
CZ (1) CZ298851B6 (hu)
DE (1) DE69817848T2 (hu)
ES (1) ES2205558T3 (hu)
HU (1) HU225692B1 (hu)
IT (1) IT1295271B1 (hu)
NO (1) NO20001709L (hu)
SK (1) SK284552B6 (hu)
WO (1) WO1999017745A1 (hu)
ZA (1) ZA989010B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003041646A2 (en) 2001-11-13 2003-05-22 Teva Pharmaceutical Industries, Ltd. L-dopa ethyl ester salts and uses thereof
US20030224045A1 (en) * 2002-05-29 2003-12-04 Chien-Hsuan Han Combination immediate release sustained release levodopa/carbidopa dosage forms
US7094427B2 (en) * 2002-05-29 2006-08-22 Impax Laboratories, Inc. Combination immediate release controlled release levodopa/carbidopa dosage forms
CA2613631A1 (en) * 2005-06-23 2007-01-04 Spherics, Inc. Improved dosage forms for movement disorder treatment
ATE489079T1 (de) 2005-12-29 2010-12-15 Osmotica Kereskedelmi Es Szolgaltata Kft Mehrschichtige tablette mit dreifacher freisetzungskombination
MX340249B (es) 2008-08-15 2016-07-01 Depomed Inc Composiciones farmacéuticas retentivas gástricas para tratamiento y prevención de transtornos del sistema nervioso central (cns).
CA2832436C (en) * 2010-04-07 2018-08-14 Lupin Limited Controlled release pharmaceutical compositions of tapentadol
EP2508174A1 (en) 2011-04-06 2012-10-10 Ljiljana Sovic Brkicic Pharmaceutical composition
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
ITMI20121263A1 (it) 2012-07-19 2014-01-20 Recordati Ind Chimica E Farma Ceutica S P A Forma farmaceutica multistrato
EP3878445A3 (en) 2013-06-05 2021-10-27 Synchroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
EP3054929B1 (en) * 2013-10-07 2020-08-05 Impax Laboratories, LLC Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
US9808478B2 (en) * 2015-04-17 2017-11-07 Steven Loyd Control release of fat soluble antioxidants from an oral formulation and method
EP3364955B1 (en) 2015-10-09 2022-04-20 RB Health (US) LLC Pharmaceutical formulation
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili

Also Published As

Publication number Publication date
AR043070A1 (es) 2005-07-20
ITMI972254A1 (it) 1999-04-03
BR9815248A (pt) 2000-11-21
SK4822000A3 (en) 2000-09-12
ES2205558T3 (es) 2004-05-01
NO20001709L (no) 2000-06-05
WO1999017745A1 (en) 1999-04-15
ATE248590T1 (de) 2003-09-15
CZ20001200A3 (cs) 2000-09-13
ZA989010B (en) 1999-04-12
DE69817848D1 (de) 2003-10-09
DE69817848T2 (de) 2005-04-07
HU225692B1 (en) 2007-06-28
AU9629198A (en) 1999-04-27
EP1019029B1 (en) 2003-09-03
IT1295271B1 (it) 1999-05-04
NO20001709D0 (no) 2000-04-03
EP1019029A1 (en) 2000-07-19
SK284552B6 (sk) 2005-06-02
HUP0004015A3 (en) 2006-06-28
CZ298851B6 (cs) 2008-02-27

Similar Documents

Publication Publication Date Title
HUP0004015A2 (hu) Három különböző, egyenként legalább egy hatóanyagot tartalmazó rétegből álló monolitikus, orális rendszer
ID21259A (id) Sistim penyaluran obat untuk dua atau lebih bahan-bahan aktif
HUP0100406A2 (hu) Egy vagy több hatóanyag azonnali és tartós felszabadulását biztosító tabletta
DE50008336D1 (de) Mehrschichttablette zur verabreichung einer fixen kombination von tramadol und diclofenac
HUP0202497A2 (hu) Orális, hidrodinamikailag szabályozott hatóanyag leadású készítmény
MX9706769A (es) Formas de dosificacion farmaceutica que comprenden un inhibidor de la bomba de protones y un agente procinetico.
MY114889A (en) 1-phenyl-3-dimethylamino-propane derivatives having pharmacological activity
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
DK0742711T3 (da) Tabletter, som er beskyttet mod misbrug
HUP0002935A2 (hu) Gyomorban visszatartott, szabályozott hatóanyag kibocsátású mikrogömböcskék javított gyógyszeradagolás elősegítésére
NO317747B1 (no) Farmasoytisk preparat samt anvendelse derav
HUP0201788A2 (en) Multilayered film containing an active substance and made of cross-linked hydrophilic polymers
PT1091975E (pt) Nova ciclosporina com um perfil de actividade melhorado
NO305906B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
WO2003015779A3 (de) Matrixkontrolliertes transdermales therapeutisches system zur anwendung von pramipexol und ropinirol
ME00578A (en) Use of gastrointestinal lipase inhibitors
BG103714A (en) Pararacetamol-containing tablet
SE9700885D0 (sv) New pharmaceutical formulation
FR2718020B1 (fr) Composition galénique mucoadhésive hétérofonctionnelle.
IT1293910B1 (it) Bracciolo di sedia, e sedia utilizzante tale bracciolo.
HUP9802423A2 (hu) Hiperproliferatív megbetegedések kombinált gyógyászati kezelése
HUP0002346A1 (hu) Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
ATE252096T1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
NO306113B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
HUP0003341A2 (hu) Orális adagolásra alkalmas rapamicinkészítmények

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees